semaglutide by mouth does leave a taste in your “Ozempic mouth” 👅 is common phrase for changes Dry Mouth Relief for GLP-1

CLA: Best for reducing overall body fat and preserving muscle mass

Glucagon-like peptide-1 receptor agonists and gastrointestinal adverse events: a systematic review and meta-analysis

GIP is a separate gut hormone that regulates insulin and appetite

Adding 2mL of bacteriostatic water to a 10mg vial creates a 5mg/mL (5,000mcg/mL) concentration

CagriSema is composed of the GLP-1 RA semaglutide and the long-acting insulin analog cagrilintide, and can be administered subcutaneously once a week.117 Beinaglutide Beinaglutide was the first original drug approved for the treatment of obesity in China and the third GLP-1 class reduction drug approved worldwide, and it represents a new treatment option for overweight and obese patients.67,118,119 Beinaglutide, a recombinant human GLP-1 (rhGLP-1) polypeptide, exhibits a remarkable resemblance to human GLP-1(7-36), with nearly 100% homology.120 This innovative compound demonstrates dose-dependent efficacy in regulating glycemic control, suppressing appetite, delaying gastric emptying, and facilitating weight reduction.121 Consequently, beinaglutide holds significant promise for advancing research in the areas of overweight/obesity and nonalcoholic steatohepatitis (NASH).67,122 Beinaglutide is a natural human GLP-1(7-36)-NH2 expressed in Escherichia coli